Bank of New York Mellon Corp Has $643.34 Million Position in CVS Health Corporation $CVS

Bank of New York Mellon Corp cut its stake in CVS Health Corporation (NYSE:CVS) by 1.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,533,512 shares of the pharmacy operator’s stock after selling 122,098 shares during the quarter. Bank of New York Mellon Corp’s holdings in CVS Health were worth $643,341,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Avion Wealth lifted its holdings in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. lifted its stake in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new stake in CVS Health in the third quarter worth approximately $29,000. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health during the 2nd quarter worth $30,000. Finally, Front Row Advisors LLC lifted its stake in shares of CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS shares rose while the broader market fell, reflecting short-term buying interest and risk-on flows. Zacks Article
• Positive Sentiment: Short interest fell ~13.4% in January to ~18.76M shares (1.5% of float), lowering potential downward pressure from short sellers and reducing squeeze risk (days-to-cover ~2.5). Short Interest Data
• Positive Sentiment: An executive vice president disclosed a small open-market buy (24 shares at ~$53.70 on Jan. 23), a modest insider signal of confidence. SEC Form 4
• Neutral Sentiment: Analysts at Argus cut their price target slightly from $91 to $90 but kept a “buy” rating (still showing material upside), signaling continued analyst support despite the trim. The Fly
• Neutral Sentiment: Bank of America lowered its target from $100 to $95 but maintained a “buy” stance, also implying continued conviction in longer-term upside despite near-term adjustments. Benzinga
• Negative Sentiment: The administration’s proposal to keep Medicare rates roughly flat has pressured Medicare-related revenue expectations for payers and pharmacy benefit managers, contributing to earlier selloffs and ongoing margin concerns for CVS. Barron’s
• Negative Sentiment: A House Judiciary report and related coverage allege CVS used tactics to limit competition from rival pharmacy hubs, introducing regulatory and legal risk that could increase compliance costs or fines. HealthcareDive

CVS Health Stock Up 3.0%

Shares of CVS stock opened at $74.14 on Thursday. The stock has a 50 day moving average of $79.01 and a 200-day moving average of $75.02. The firm has a market cap of $94.12 billion, a PE ratio of 195.11, a price-to-earnings-growth ratio of 0.66 and a beta of 0.48. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 12 month low of $53.36 and a 12 month high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same period in the prior year, the company earned $1.09 EPS. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. On average, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. CVS Health’s dividend payout ratio is currently 700.00%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent research reports. Bank of America cut their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday. Argus cut their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday. Truist Financial set a $100.00 target price on CVS Health in a research report on Wednesday, December 10th. Wells Fargo & Company dropped their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Finally, TD Cowen upped their price objective on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.82.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.